ID   FSP1_HUMAN              Reviewed;         373 AA.
AC   Q9BRQ8; B3KXI0; Q63Z39;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   18-JUN-2025, entry version 182.
DE   RecName: Full=Ferroptosis suppressor protein 1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900};
DE            Short=FSP1 {ECO:0000303|PubMed:31634899, ECO:0000303|PubMed:31634900};
DE            EC=1.6.5.- {ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516};
DE   AltName: Full=Apoptosis-inducing factor homologous mitochondrion-associated inducer of death {ECO:0000303|PubMed:11980907};
DE            Short=AMID {ECO:0000303|PubMed:11980907};
DE   AltName: Full=p53-responsive gene 3 protein {ECO:0000303|PubMed:12135761};
GN   Name=AIFM2 {ECO:0000303|PubMed:26689472, ECO:0000312|HGNC:HGNC:21411};
GN   Synonyms=AMID {ECO:0000303|PubMed:11980907}, PRG3
GN   {ECO:0000303|PubMed:12135761};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAL73229.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INDUCTION, AND CAUTION.
RX   PubMed=12135761; DOI=10.1016/s0014-5793(02)03049-1;
RA   Ohiro Y., Garkavtsev I., Kobayashi S., Sreekumar K.R., Nantz R.,
RA   Higashikubo B.T., Duffy S.L., Higashikubo R., Usheva A., Gius D., Kley N.,
RA   Horikoshi N.;
RT   "A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the
RT   apoptosis-inducing factor (AIF).";
RL   FEBS Lett. 524:163-171(2002).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAM77596.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND CAUTION.
RX   PubMed=11980907; DOI=10.1074/jbc.m202285200;
RA   Wu M., Xu L.-G., Li X., Zhai Z., Shu H.-B.;
RT   "AMID, an apoptosis-inducing factor-homologous mitochondrion-associated
RT   protein, induces caspase-independent apoptosis.";
RL   J. Biol. Chem. 277:25617-25623(2002).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAB55089.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AL731540}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:CAH56481.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAH06121.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney {ECO:0000312|EMBL:AAH06121.1}, and Lung
RC   {ECO:0000312|EMBL:AAH23601.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 23-373 (ISOFORM 2).
RC   TISSUE=Esophageal carcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=15273740; DOI=10.1038/sj.onc.1207909;
RA   Wu M., Xu L.-G., Su T., Tian Y., Zhai Z., Shu H.-B.;
RT   "AMID is a p53-inducible gene downregulated in tumors.";
RL   Oncogene 23:6815-6819(2004).
RN   [9] {ECO:0000305}
RP   FUNCTION, COFACTOR, AND CAUTION.
RX   PubMed=15958387; DOI=10.1074/jbc.m414018200;
RA   Marshall K.R., Gong M., Wodke L., Lamb J.H., Jones D.J., Farmer P.B.,
RA   Scrutton N.S., Munro A.W.;
RT   "The human apoptosis-inducing protein AMID is an oxidoreductase with a
RT   modified flavin cofactor and DNA binding activity.";
RL   J. Biol. Chem. 280:30735-30740(2005).
RN   [10]
RP   MYRISTOYLATION AT GLY-2.
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25255805; DOI=10.1038/ncomms5919;
RA   Thinon E., Serwa R.A., Broncel M., Brannigan J.A., Brassat U., Wright M.H.,
RA   Heal W.P., Wilkinson A.J., Mann D.J., Tate E.W.;
RT   "Global profiling of co- and post-translationally N-myristoylated proteomes
RT   in human cells.";
RL   Nat. Commun. 5:4919-4919(2014).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND CAUTION.
RX   PubMed=26689472; DOI=10.1016/j.freeradbiomed.2015.12.002;
RA   Miriyala S., Thippakorn C., Chaiswing L., Xu Y., Noel T., Tovmasyan A.,
RA   Batinic-Haberle I., Vander Kooi C.W., Chi W., Latif A.A., Panchatcharam M.,
RA   Prachayasittikul V., Butterfield D.A., Vore M., Moscow J., St Clair D.K.;
RT   "Novel role of 4-hydroxy-2-nonenal in AIFm2-mediated mitochondrial stress
RT   signaling.";
RL   Free Radic. Biol. Med. 91:68-80(2016).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, MYRISTOYLATION AT GLY-2, MUTAGENESIS OF
RP   GLY-2, AND CAUTION.
RX   PubMed=31634899; DOI=10.1038/s41586-019-1707-0;
RA   Doll S., Freitas F.P., Shah R., Aldrovandi M., da Silva M.C., Ingold I.,
RA   Grocin A.G., Xavier da Silva T.N., Panzilius E., Scheel C., Mourao A.,
RA   Buday K., Sato M., Wanninger J., Vignane T., Mohana V., Rehberg M.,
RA   Flatley A., Schepers A., Kurz A., White D., Sauer M., Sattler M.,
RA   Tate E.W., Schmitz W., Schulze A., O'Donnel V., Proneth B., Popowicz G.M.,
RA   Pratt D., Angeli J.P.F., Conrad M.;
RT   "FSP1 is a glutathione-independent ferroptosis suppressor.";
RL   Nature 575:693-698(2019).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, MYRISTOYLATION AT GLY-2, SUBCELLULAR
RP   LOCATION, MUTAGENESIS OF GLU-156, AND CAUTION.
RX   PubMed=31634900; DOI=10.1038/s41586-019-1705-2;
RA   Bersuker K., Hendricks J., Li Z., Magtanong L., Ford B., Tang P.H.,
RA   Roberts M.A., Tong B., Maimone T.J., Zoncu R., Bassik M.C., Nomura D.K.,
RA   Dixon S.J., Olzmann J.A.;
RT   "The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
RT   ferroptosis.";
RL   Nature 575:688-692(2019).
RN   [16]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=35922516; DOI=10.1038/s41586-022-05022-3;
RA   Mishima E., Ito J., Wu Z., Nakamura T., Wahida A., Doll S., Tonnus W.,
RA   Nepachalovich P., Eggenhofer E., Aldrovandi M., Henkelmann B., Yamada K.I.,
RA   Wanninger J., Zilka O., Sato E., Feederle R., Hass D., Maida A.,
RA   Mourao A.S.D., Linkermann A., Geissler E.K., Nakagawa K., Abe T.,
RA   Fedorova M., Proneth B., Pratt D.A., Conrad M.;
RT   "A non-canonical vitamin K cycle is a potent ferroptosis suppressor.";
RL   Nature 608:778-783(2022).
RN   [17]
RP   FUNCTION, ACETYLATION AT LYS-168, UBIQUITINATION, AND MUTAGENESIS OF
RP   LYS-168.
RX   PubMed=39881208; DOI=10.1038/s44318-025-00369-5;
RA   Li W., Han J., Huang B., Xu T., Wan Y., Luo D., Kong W., Yu Y., Zhang L.,
RA   Nian Y., Chu B., Yin C.;
RT   "SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis
RT   susceptibility via FSP1 acetylation.";
RL   EMBO J. 0:0-0(2025).
CC   -!- FUNCTION: A NAD(P)H-dependent oxidoreductase that acts as a key
CC       inhibitor of ferroptosis (PubMed:31634899, PubMed:31634900,
CC       PubMed:35922516, PubMed:39881208). At the plasma membrane, catalyzes
CC       reduction of coenzyme Q/ubiquinone-10 to ubiquinol-10, a lipophilic
CC       radical-trapping antioxidant that prevents lipid oxidative damage and
CC       consequently ferroptosis (PubMed:31634899, PubMed:31634900). Acts in
CC       parallel to GPX4 to suppress phospholipid peroxidation and ferroptosis
CC       (PubMed:31634899, PubMed:31634900). This anti-ferroptotic function is
CC       independent of cellular glutathione levels (PubMed:31634899,
CC       PubMed:31634900). Also acts as a potent radical-trapping antioxidant by
CC       mediating warfarin-resistant vitamin K reduction in the canonical
CC       vitamin K cycle: catalyzes NAD(P)H-dependent reduction of vitamin K
CC       (phylloquinone, menaquinone-4 and menadione) to hydroquinone forms
CC       (PubMed:35922516). Hydroquinones act as potent radical-trapping
CC       antioxidants inhibitor of phospholipid peroxidation and ferroptosis
CC       (PubMed:35922516). May play a role in mitochondrial stress signaling
CC       (PubMed:26689472). Upon oxidative stress, associates with the lipid
CC       peroxidation end product 4-hydroxy-2-nonenal (HNE) forming a lipid
CC       adduct devoid of oxidoreductase activity, which then translocates from
CC       mitochondria into the nucleus triggering DNA damage and cell death
CC       (PubMed:26689472). Capable of DNA binding in a non-sequence specific
CC       way (PubMed:15958387). {ECO:0000269|PubMed:15958387,
CC       ECO:0000269|PubMed:26689472, ECO:0000269|PubMed:31634899,
CC       ECO:0000269|PubMed:31634900, ECO:0000269|PubMed:35922516,
CC       ECO:0000269|PubMed:39881208}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ubiquinone-10 + NADH + H(+) = ubiquinol-10 + NAD(+);
CC         Xref=Rhea:RHEA:61984, ChEBI:CHEBI:15378, ChEBI:CHEBI:46245,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:64183;
CC         Evidence={ECO:0000305|PubMed:31634899, ECO:0000305|PubMed:31634900};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61985;
CC         Evidence={ECO:0000305|PubMed:31634899, ECO:0000305|PubMed:31634900};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=phylloquinone + NADH + H(+) = phylloquinol + NAD(+);
CC         Xref=Rhea:RHEA:74075, ChEBI:CHEBI:15378, ChEBI:CHEBI:18067,
CC         ChEBI:CHEBI:28433, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:35922516};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:74076;
CC         Evidence={ECO:0000269|PubMed:35922516};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=menaquinone-4 + NADH + H(+) = menaquinol-4 + NAD(+);
CC         Xref=Rhea:RHEA:74079, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:78277, ChEBI:CHEBI:193091;
CC         Evidence={ECO:0000269|PubMed:35922516};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:74080;
CC         Evidence={ECO:0000269|PubMed:35922516};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=menadione + NADH + H(+) = menadiol + NAD(+);
CC         Xref=Rhea:RHEA:69695, ChEBI:CHEBI:6746, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28869, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:35922516};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69696;
CC         Evidence={ECO:0000269|PubMed:35922516};
CC   -!- COFACTOR:
CC       Name=6-hydroxy-FAD; Xref=ChEBI:CHEBI:60470;
CC         Evidence={ECO:0000269|PubMed:15958387};
CC       Note=Binds 6-hydroxy-FAD non-covalently. {ECO:0000269|PubMed:15958387};
CC   -!- ACTIVITY REGULATION: The modification by 4-hydroxy-2-nonenal (HNE)
CC       adduction in mitochondria results in loss of the oxidoreductase
CC       activity and activation of a novel function in mitochondrial oxidative
CC       stress signaling. {ECO:0000250|UniProtKB:Q8BUE4}.
CC   -!- SUBUNIT: Interacts with importin subunits KPNA2 and IPO5; this
CC       interaction likely mediates the translocation into the nucleus upon
CC       oxidative stress. {ECO:0000250|UniProtKB:Q8BUE4}.
CC   -!- INTERACTION:
CC       Q9BRQ8; Q8N129: CNPY4; NbExp=3; IntAct=EBI-3956936, EBI-723824;
CC       Q9BRQ8; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-3956936, EBI-2130429;
CC       Q9BRQ8; Q86WT6-2: TRIM69; NbExp=3; IntAct=EBI-3956936, EBI-11525489;
CC   -!- SUBCELLULAR LOCATION: Lipid droplet {ECO:0000269|PubMed:31634900}. Cell
CC       membrane {ECO:0000269|PubMed:31634900}; Lipid-anchor {ECO:0000305}.
CC       Cytoplasm {ECO:0000269|PubMed:11980907, ECO:0000269|PubMed:12135761,
CC       ECO:0000269|PubMed:26689472}. Mitochondrion membrane
CC       {ECO:0000269|PubMed:11980907, ECO:0000269|PubMed:26689472}. Nucleus
CC       {ECO:0000269|PubMed:26689472}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:11980907, ECO:0000269|PubMed:12135761};
CC         IsoId=Q9BRQ8-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:15489334};
CC         IsoId=Q9BRQ8-2; Sequence=VSP_052047, VSP_052048;
CC   -!- TISSUE SPECIFICITY: Detected in most normal tissues as two transcripts
CC       of 1.8 and 4.0 kb in length, respectively. Highly expressed in heart,
CC       moderately in liver and skeletal muscles, and expressed at low levels
CC       in placenta, lung, kidney, and pancreas. Both transcripts expressed
CC       following p53/TP53 induction. The shorter 1.8 kb transcript seems to be
CC       the major transcript in EB1 colon cancer cells.
CC       {ECO:0000269|PubMed:12135761}.
CC   -!- INDUCTION: Expression detected at 4 hours after induction by p53/TP53.
CC       Down-regulated in a wide range of human tumors.
CC       {ECO:0000269|PubMed:12135761, ECO:0000269|PubMed:15273740}.
CC   -!- PTM: N-myristoylation at Gly-2 mediates the recruitment to lipid
CC       droplets and plasma membrane, enabling its anti-lipid peroxidation
CC       activity. {ECO:0000269|PubMed:31634900}.
CC   -!- PTM: Acetylation at Lys-168 prevents AIFM2 ubiquitination and
CC       degradation, thereby inhibiting ferroptosis. KAT2B mediates acetylation
CC       at Lys-168, while HDAC3 removes it. {ECO:0000269|PubMed:39881208}.
CC   -!- PTM: Ubiquitinated. AIFM2 undergoes 'Lys-29'-ubiquitination and
CC       proteasomal degradation, which is inhibited by acetylation at Lys-168.
CC       {ECO:0000269|PubMed:39881208}.
CC   -!- SIMILARITY: Belongs to the FAD-dependent oxidoreductase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Conflicting data exist on the pro-apoptotic function of the
CC       protein. It was initially claimed that overexpression of FSP1 induces
CC       caspase-independent apoptosis, but new evidence disputes this function.
CC       {ECO:0000269|PubMed:11980907, ECO:0000269|PubMed:12135761,
CC       ECO:0000269|PubMed:15958387, ECO:0000269|PubMed:26689472,
CC       ECO:0000269|PubMed:31634899, ECO:0000269|PubMed:31634900}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/41842/AIFM2";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=On a tightrope - Issue 254
CC       of January 2023;
CC       URL="https://www.proteinspotlight.org/back_issues/254/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF337957; AAL73229.1; -; mRNA.
DR   EMBL; AF506757; AAM77596.1; -; mRNA.
DR   EMBL; AK027403; BAB55089.1; -; mRNA.
DR   EMBL; AK127353; BAG54492.1; -; mRNA.
DR   EMBL; AL731540; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54376.1; -; Genomic_DNA.
DR   EMBL; BC006121; AAH06121.1; -; mRNA.
DR   EMBL; BC023601; AAH23601.1; -; mRNA.
DR   EMBL; BX537621; CAH56481.1; -; mRNA.
DR   CCDS; CCDS7297.1; -. [Q9BRQ8-1]
DR   RefSeq; NP_001185625.1; NM_001198696.2. [Q9BRQ8-1]
DR   RefSeq; NP_116186.1; NM_032797.6. [Q9BRQ8-1]
DR   PDB; 8JSC; X-ray; 2.16 A; C=2-373.
DR   PDB; 8WIK; X-ray; 2.00 A; A=1-373.
DR   PDB; 8YO8; X-ray; 2.00 A; A=10-373.
DR   PDB; 8YOQ; X-ray; 1.79 A; A=10-373.
DR   PDB; 8YOX; X-ray; 2.48 A; A=10-373.
DR   PDBsum; 8JSC; -.
DR   PDBsum; 8WIK; -.
DR   PDBsum; 8YO8; -.
DR   PDBsum; 8YOQ; -.
DR   PDBsum; 8YOX; -.
DR   AlphaFoldDB; Q9BRQ8; -.
DR   SMR; Q9BRQ8; -.
DR   BioGRID; 124325; 35.
DR   ELM; Q9BRQ8; -.
DR   FunCoup; Q9BRQ8; 619.
DR   IntAct; Q9BRQ8; 20.
DR   STRING; 9606.ENSP00000478931; -.
DR   GlyGen; Q9BRQ8; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BRQ8; -.
DR   PhosphoSitePlus; Q9BRQ8; -.
DR   BioMuta; AIFM2; -.
DR   DMDM; 74752283; -.
DR   jPOST; Q9BRQ8; -.
DR   MassIVE; Q9BRQ8; -.
DR   PaxDb; 9606-ENSP00000478931; -.
DR   PeptideAtlas; Q9BRQ8; -.
DR   ProteomicsDB; 78808; -. [Q9BRQ8-1]
DR   ProteomicsDB; 78809; -. [Q9BRQ8-2]
DR   Pumba; Q9BRQ8; -.
DR   Antibodypedia; 14832; 290 antibodies from 36 providers.
DR   DNASU; 84883; -.
DR   Ensembl; ENST00000307864.3; ENSP00000312370.1; ENSG00000042286.15. [Q9BRQ8-1]
DR   Ensembl; ENST00000373248.5; ENSP00000362345.1; ENSG00000042286.15. [Q9BRQ8-1]
DR   Ensembl; ENST00000613322.4; ENSP00000478931.1; ENSG00000042286.15. [Q9BRQ8-1]
DR   GeneID; 84883; -.
DR   KEGG; hsa:84883; -.
DR   MANE-Select; ENST00000307864.3; ENSP00000312370.1; NM_032797.6; NP_116186.1.
DR   UCSC; uc001jqp.3; human. [Q9BRQ8-1]
DR   AGR; HGNC:21411; -.
DR   CTD; 84883; -.
DR   DisGeNET; 84883; -.
DR   GeneCards; AIFM2; -.
DR   HGNC; HGNC:21411; AIFM2.
DR   HPA; ENSG00000042286; Low tissue specificity.
DR   MIM; 605159; gene.
DR   OpenTargets; ENSG00000042286; -.
DR   VEuPathDB; HostDB:ENSG00000042286; -.
DR   eggNOG; KOG1336; Eukaryota.
DR   GeneTree; ENSGT00390000004582; -.
DR   HOGENOM; CLU_019845_2_1_1; -.
DR   InParanoid; Q9BRQ8; -.
DR   OMA; TWEIAPP; -.
DR   OrthoDB; 3244603at2759; -.
DR   PAN-GO; Q9BRQ8; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9BRQ8; -.
DR   BRENDA; 7.1.1.2; 2681.
DR   PathwayCommons; Q9BRQ8; -.
DR   Reactome; R-HSA-6803204; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release.
DR   SignaLink; Q9BRQ8; -.
DR   SIGNOR; Q9BRQ8; -.
DR   BioGRID-ORCS; 84883; 23 hits in 1149 CRISPR screens.
DR   ChiTaRS; AIFM2; human.
DR   GeneWiki; AIFM2; -.
DR   GenomeRNAi; 84883; -.
DR   Pharos; Q9BRQ8; Tbio.
DR   PRO; PR:Q9BRQ8; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9BRQ8; protein.
DR   Bgee; ENSG00000042286; Expressed in adipose tissue and 147 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; IDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0004174; F:electron-transferring-flavoprotein dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; IDA:MGI.
DR   GO; GO:1990748; P:cellular detoxification; IDA:UniProt.
DR   GO; GO:0110076; P:negative regulation of ferroptosis; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:1900407; P:regulation of cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0006743; P:ubiquinone metabolic process; IDA:UniProtKB.
DR   GO; GO:0042373; P:vitamin K metabolic process; IDA:UniProtKB.
DR   FunFam; 3.50.50.100:FF:000003; Apoptosis-inducing factor, mitochondrion-associated, 2; 1.
DR   Gene3D; 3.50.50.100; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   PANTHER; PTHR43735; APOPTOSIS-INDUCING FACTOR 1; 1.
DR   PANTHER; PTHR43735:SF3; FERROPTOSIS SUPPRESSOR PROTEIN 1; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   PRINTS; PR00368; FADPNR.
DR   PRINTS; PR00469; PNDRDTASEII.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 1.
DR   neXtProt; NX_Q9BRQ8; -.
DR   PharmGKB; PA162376150; -.
DR   TreeFam; TF329369; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane; Cytoplasm;
KW   DNA-binding; FAD; Flavoprotein; Lipid droplet; Lipoprotein; Membrane;
KW   Mitochondrion; Myristate; Nucleus; Oxidoreductase;
KW   Proteomics identification; Reference proteome; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25255805"
FT   CHAIN           2..373
FT                   /note="Ferroptosis suppressor protein 1"
FT                   /id="PRO_0000238922"
FT   TRANSMEM        7..27
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         18..22
FT                   /ligand="6-hydroxy-FAD"
FT                   /ligand_id="ChEBI:CHEBI:60470"
FT                   /evidence="ECO:0000255"
FT   BINDING         54
FT                   /ligand="6-hydroxy-FAD"
FT                   /ligand_id="ChEBI:CHEBI:60470"
FT                   /evidence="ECO:0000255"
FT   BINDING         82
FT                   /ligand="6-hydroxy-FAD"
FT                   /ligand_id="ChEBI:CHEBI:60470"
FT                   /evidence="ECO:0000255"
FT   BINDING         285
FT                   /ligand="6-hydroxy-FAD"
FT                   /ligand_id="ChEBI:CHEBI:60470"
FT                   /evidence="ECO:0000255"
FT   SITE            174
FT                   /note="4-hydroxy-2-nonenal adduction"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUE4"
FT   MOD_RES         168
FT                   /note="N6-acetyllysine; by KAT2B"
FT                   /evidence="ECO:0000269|PubMed:39881208"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:20213681,
FT                   ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:31634899,
FT                   ECO:0000269|PubMed:31634900"
FT   VAR_SEQ         99..138
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_052047"
FT   VAR_SEQ         206
FT                   /note="S -> SLLG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_052048"
FT   VARIANT         135
FT                   /note="M -> T (in dbSNP:rs10999147)"
FT                   /id="VAR_050651"
FT   VARIANT         288
FT                   /note="D -> N (in dbSNP:rs2271694)"
FT                   /id="VAR_050652"
FT   MUTAGEN         2
FT                   /note="G->A: Impairs N-myristoylation and ferroptosis
FT                   suppression."
FT                   /evidence="ECO:0000269|PubMed:31634899"
FT   MUTAGEN         156
FT                   /note="E->A: Impairs the reductase activity toward coenzyme
FT                   Q1/ubiquinone-1. Impairs ferroptosis suppression."
FT                   /evidence="ECO:0000269|PubMed:31634900"
FT   MUTAGEN         168
FT                   /note="K->Q: Acetylation-mimetic. Results in reduced
FT                   ubiquitination and increased stability of the protein."
FT                   /evidence="ECO:0000269|PubMed:39881208"
FT   MUTAGEN         168
FT                   /note="K->R: No acetylation at this site. Results in
FT                   increased ubiquitination and reduced stability of the
FT                   protein. Loss of function in negative regulation of
FT                   ferroptosis."
FT                   /evidence="ECO:0000269|PubMed:39881208"
SQ   SEQUENCE   373 AA;  40527 MW;  47F2E6F682D4C060 CRC64;
     MGSQVSVESG ALHVVIVGGG FGGIAAASQL QALNVPFMLV DMKDSFHHNV AALRASVETG
     FAKKTFISYS VTFKDNFRQG LVVGIDLKNQ MVLLQGGEAL PFSHLILATG STGPFPGKFN
     EVSSQQAAIQ AYEDMVRQVQ RSRFIVVVGG GSAGVEMAAE IKTEYPEKEV TLIHSQVALA
     DKELLPSVRQ EVKEILLRKG VQLLLSERVS NLEELPLNEY REYIKVQTDK GTEVATNLVI
     LCTGIKINSS AYRKAFESRL ASSGALRVNE HLQVEGHSNV YAIGDCADVR TPKMAYLAGL
     HANIAVANIV NSVKQRPLQA YKPGALTFLL SMGRNDGVGQ ISGFYVGRLM VRLTKSRDLF
     VSTSWKTMRQ SPP
//
